Koyfin Home > Directory > Health Care > Biogen Inc > EBITDA Margin

Biogen Inc EBITDA Margin Chart (BIIB)

Biogen Inc annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Biogen Inc EBITDA Margin for the quarter ending June 06, 2020 was $57m a 0.20% increase of 0m year over year
  • Biogen Inc EBITDA Margin for the last 12 months ending June 06, 2020 was $56m a 2.06% increase of 1m year over year
  • Biogen Inc Annual EBITDA Margin for 2019 was $54m a 3.14% increase of 2m from 2018
  • Biogen Inc Annual EBITDA Margin for 2018 was $52m a -3.25% decrease of -2m from 2017
  • Biogen Inc Annual EBITDA Margin for 2017 was $54m a -2.96% decrease of -2m from 2016
Other Margins & Efficiency Metrics:
  • Biogen Inc Return on Capital % for the quarter ending December 12, 2018 was 20.45 a -0.53% decrease of -0.11 year over year
  • Biogen Inc Return on Equity % for the quarter ending December 12, 2018 was 28.21 a -24.67% decrease of -6.96 year over year
View Chart On Koyfin

Quarterly BIIB EBITDA Margin Data

06/2020$57m
03/2020$57m
12/2019$50m
09/2019$57m
06/2019$57m
03/2019$50m
12/2018$53m
09/2018$58m
06/2018$44m
03/2018$55m

Annual BIIB EBITDA Margin Data

2019$54m
2018$52m
2017$54m
2016$55m
2015$52m
2014$47m
2013$44m
2012$40m
2011$42m
2010$41m